Patterns and outcomes of drug-eluting coronary stent use in clinical practice
- 31 August 2006
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 152 (2) , 321-326
- https://doi.org/10.1016/j.ahj.2006.03.005
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005
- Antithrombotic Therapy During Percutaneous Coronary InterventionChest, 2004
- Bleeding events with abciximab in acute coronary syndromes without early revascularization: an analysis of GUSTO IV–ACSAmerican Heart Journal, 2004
- Drug‐eluting stent task force: Final report and recommendations of the working committees on cost‐effectiveness/economics, access to care, and medicolegal issuesCatheterization and Cardiovascular Interventions, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Racial Disparity in Cardiac Procedures and Mortality Among Long-Term Survivors of Cardiac ArrestCirculation, 2003
- Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart DiseaseNew England Journal of Medicine, 2002
- The American College of Cardiology-National Cardiovascular Data Registry™ (ACC-NCDR™): building a national clinical data repositoryJournal of the American College of Cardiology, 2001